Lifestyle Intervention, Fat and Lean Mass, and Risk for Heart Failure, MI
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
Diabetes Information Center
Acute COPD Exacerbations May Be Linked to Higher HbA1c Levels
Patients with chronic obstructive pulmonary disease (COPD) who have higher levels of HbA1c are at increased risk for hospital admission for acute exacerbations.
High Dietary Inflammatory or Insulinemic Potential May Increase Risk for Type 2 Diabetes
Researchers sought to identify the association between proinflammatory and hyperinsulinemic diets with type 2 diabetes risk.
HIV, Hepatitis-B Drugs Proven to Reduce Risk of Type 2 Diabetes
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
FDA Approvals That NPs, PAs Should Know
The FDA approved therapies to treat pain, type 2 diabetes, hormone deficiency, and juvenile idiopathic arthritis in September 2020.
Nurse-Focused Diabetes Care Improves Patient Outcomes
A longitudinal care model for diabetes management that puts registered nurses in charge of overseeing a proactive and personalized intervention for diabetes patients resulted in enhanced care.
Exposure to Maternal Gestational Diabetes Tied to Higher CVD Risk
Intrauterine exposure to maternal gestational diabetes is associated with an increased cardiovascular disease risk and risk factors in offspring up to age 35 years.
Individualized Care Necessary for Diabetes Patients in Psychiatric Inpatient Settings
Researchers developed a quality improvement project protocol to describe ways to support diabetes management in psychiatric inpatient settings.
Diabetes, CVD, and Mood Disorders Are Highly Prevalent in Patients With Palmoplantar Plaque Psoriasis
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.
Higher Triglyceride Levels Linked to Adverse Cardiovascular Outcomes
Researchers sought to determine whether triglyceride levels were independently associated with cardiovascular disease among patients with coronary artery disease and type 2 diabetes.
Diabetic Ketoacidosis Rates in Children With New T1D Diagnosis During COVID-19
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
Comorbid Diabetes and COVID-19 Linked to Longer Hospitalization
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and longer hospital stays.
Assessing Prevalence, Treatment of Patients With Severe Hypercholesterolemia
Researchers used electronic health records to further understand the clinical features and gaps in treatment approaches for patients with severe hypercholesterolemia.
Many US Children Eligible for Type 2 Diabetes Screening
Many children are eligible for type 2 diabetes screening, but few test positive for prediabetes or diabetes.
OSA Severity Reduced in Type 2 Diabetes With Lifestyle Interventions for Weight Loss
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
Cinnamon Supplementation May Improve Blood Glucose Control
In individuals with prediabetes, 12 weeks of cinnamon supplementation improved fasting plasma glucose and glucose tolerance.
Caring for Older Adults With Diabetes During COVID-19: Guidance for Clinicians
Two clinicians share their thoughts on best practices in navigating pandemic-related care for older adults with diabetes.
Flu Vaccine Reduces Cardiovascular Mortality in Adults With Diabetes
The analysis included 241,551 patients monitored for a median of 4 years.
FDA: Several Companies Recall Metformin ER Over NDMA Concerns
Several companies have initiated recalls of metformin extended-release tablets due to the possibility of unacceptable levels of N-Nitrosodimethylamine, a probable human carcinogen.
Hyperglycemia Linked to Higher Mortality in COVID-19 Patients
For COVID-19 patients without a previous diagnosis of diabetes, fasting blood glucose (FBG) ≥7.0 mmol/L is an independent predictor of 28-day mortality.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Diabetes Information Center
